EWA
AVNS

EP Wealth Advisors’s Avanos Medical AVNS Stock Holding History

EP Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,136
Closed -$254K – 1726
2026
Q1 		$254K Buy
18,136
+279
+2% +$3.76K ﹤0.01% 1263
2025
Q4 		$201K Buy
+17,857
New +$204K ﹤0.01% 1390
2025
Q2 		$171K Sell
13,986
-797
-5% -$10K ﹤0.01% 1291
2025
Q1 		$212K Buy
14,783
+4,675
+46% +$73K ﹤0.01% 1107
2024
Q4 		$161K Buy
10,108
+1,289
+15% +$25.5K ﹤0.01% 1134
2024
Q3 		$212K Buy
+8,819
New +$202K ﹤0.01% 1022

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

EP Wealth Advisors's AVNS Position: Q2 2026 in Review

EP Wealth Advisors sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 18,136 shares — an estimated $254K sold.

EP Wealth Advisors first reported a position in AVNS in Q3 2024 and held it in 6 quarters. The position peaked at $254K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • EP Wealth Advisors reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • EP Wealth Advisors sold 18,136 Avanos Medical shares in Q2 2026, an estimated $254K.
  • EP Wealth Advisors first reported a position in Avanos Medical in Q3 2024 and held it in 6 quarters.
  • EP Wealth Advisors's Avanos Medical position peaked at $254K in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.